By Iain Gilbert
Date: Friday 12 Dec 2025
(Sharecast News) - hVIVO traded higher on Friday on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
"The funding environment for biotech has been at a lull relative to the heights that were enjoyed...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news